According to a recent study, race and ethnicity may not be associated with access to biologics for psoriasis patients in the United States.
Maternal high protein diet linked to AD during first year of life
According to a new study, a maternal high protein diet may be a risk factor for infantile atopic dermatitis (AD) during the first year of life.
QoL impairment and worse symptoms in PsO, AD linked to differing views on disease severity
According to a new study, psoriasis and atopic dermatitis (AD) patients may have differing views on disease severity, a phenomenon known as discordant severity grading. This phenomenon has been linked to higher symptom expression and greater quality of life (QoL) impairment.
Majority of psoriasis patients prefer home narrowband UV-B therapy over in-office therapy
Approximately two thirds of psoriasis patients who received home narrowband ultraviolet-B (UV-B) therapy did not use systemic therapy or in-office UV-B therapy for one year after starting at-home treatment, according to a new study.
Study shows hypertension, metabolic syndrome, waist circumference can increase psoriasis risk
According to a recent study, investigators have linked metabolic syndrome, waist circumference, and hypertension to increased psoriasis risk.
Habit replacement helps decrease instances of skin picking and nail biting
Habit replacement may be an effective approach for treating body-focused repetitive behaviours (BFRB) such as skin picking and nail biting, according to a recent study.
Women with HS report higher infertility rates
According to a new study, women with hidradenitis suppurativa (HS) report higher infertility rates than those without HS. Most patients saw no change in HS symptoms during fertility treatment.
Psoriasis patients across all Fitzpatrick skin types respond well to CAL/BDP cream
According to a new study, plaque psoriasis patients with Fitzpatrick skin types IV through VI treated with calciprotriene/betamethasone dipropionate (CAL/BDP) cream respond in a similar manner as those with Fitzpatrick skin types I through III.
Dupilumab shows rapid improvement in AD severity for pediatric patients
According to a new study, dupilumab has been shown to reduce severity and improve quality of life (QoL) in pediatric patients with atopic dermatitis (AD) two weeks after treatment.
New study shows probiotic has positive effect on pediatric AD patients
According to a new study, a single-strain probiotic was found to have a positive effect on atopic dermatitis (AD) in pediatric patients.
HealthMinute.TV 